Wednesday, 20 September 2017
Things should normalise for pharma sector from FY20-21: S Ramesh, Lupin
Talking to ET Now, S Ramesh, CFO, Lupin , says there were problems associated with manufacturing in America itself but that those problems are behind the company now. Edited excerpts:
You can read more here: Things should normalise for pharma sector from FY20-21: S Ramesh, Lupin
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
No comments:
Post a Comment